At the same time, the lactate in TME can inhibit TLR3 and its downstream IFN-I and the stimulator of interferon genes (STING), which accelerates the degradation of antigen, affects the cross-presentation ability of DCs, and thus fails to initiate the anti-tumor response (50). This evidence concerns the gene STING1 and neoplasm.